Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Operating Expenses (2010 - 2026)

Updated

Ani Pharmaceuticals (ANIP) reported Operating Expenses of $225.58 million for Q2 2026, up 14.2% from $197.48 million a year earlier and up 13.6% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Operating Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ani Pharmaceuticals' Operating Expenses came in at $828.02 million, up 13.1% year-over-year; for FY2025, it came in at $772.27 million, up 25.8% from FY2024.

  • Operating Expenses has increased for 13 consecutive years, with a five-year compound annual growth rate of 28.0% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $613.79 million in FY2024 (+39.5%), $439.85 million in FY2023 (+25.1%), $351.67 million in FY2022 (+37.4%) and $255.93 million in FY2021 (+14.0%).
  • The Q2 2026 figure ranks as the highest quarterly Operating Expenses in data going back to Q2 2010.
  • Year over year, Operating Expenses has now increased in each of the last 21 quarters, with growth averaging 31.5% over the last eight quarters.
  • The year-over-year growth in Operating Expenses has ranged between 8.9% (Q4 2025) and 62.5% (Q1 2022) over the last five years.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $198.57 million (Q1 2026), $212.29 million (Q4 2025) and $191.57 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn 225.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 225.58 Mn
Mar 31, 2026 198.57 Mn
Dec 31, 2025 212.29 Mn
Sep 30, 2025 191.57 Mn
Jun 30, 2025 197.48 Mn
Mar 31, 2025 170.93 Mn
Dec 31, 2024 194.95 Mn
Sep 30, 2024 168.85 Mn
Jun 30, 2024 132.87 Mn
Mar 31, 2024 117.12 Mn
Dec 31, 2023 124.93 Mn
Sep 30, 2023 113.88 Mn
Jun 30, 2023 104.15 Mn
Mar 31, 2023 96.89 Mn
Dec 31, 2022 92.41 Mn
Sep 30, 2022 88.82 Mn
Jun 30, 2022 86.77 Mn
Mar 31, 2022 83.67 Mn
Dec 31, 2021 84.65 Mn
Sep 30, 2021 55.62 Mn
API Access

Ani Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=ANIP&period=max&api_key=YOUR_API_KEY